|
PDE12 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.83090000014519E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.49679999997365E-06 |
| Normal-vs-Stage2 |
4.780100E-02 |
| Normal-vs-Stage3 |
3.86340000002594E-06 |
| Normal-vs-Stage4 |
2.19249999999782E-06 |
| Stage1-vs-Stage2 |
1.136240E-01 |
| Stage1-vs-Stage3 |
3.304600E-01 |
| Stage1-vs-Stage4 |
8.996500E-02 |
| Stage2-vs-Stage3 |
4.987500E-02 |
| Stage2-vs-Stage4 |
1.559790E-02 |
| Stage3-vs-Stage4 |
3.996200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.16599999947454E-07 |
| Normal-vs-AfricanAmerican |
4.262000E-02 |
| Normal-vs-Asian |
1.351330E-04 |
| Caucasian-vs-AfricanAmerican |
3.933600E-01 |
| Caucasian-vs-Asian |
5.736600E-01 |
| AfricanAmerican-vs-Asian |
2.936200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.41250000029736E-07 |
| Normal-vs-Female |
2.14759999999092E-05 |
| Male-vs-Female |
3.298400E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.05529999999232E-05 |
| Normal-vs-Age(41-60Yrs) |
7.4429999996628E-07 |
| Normal-vs-Age(61-80Yrs) |
9.162100E-04 |
| Normal-vs-Age(81-100Yrs) |
9.400000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.869400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.706000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.847600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.984200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.293200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.961800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.544000E-02 |
| Classical-VS-Follicular |
9.406000E-01 |
| Classical-VS-Other |
7.568100E-02 |
| Classical-VS-Normal |
2.45849999999104E-05 |
| Tall-VS-Follicular |
1.514380E-01 |
| Tall-VS-Other |
2.035800E-01 |
| Tall-VS-Normal |
2.26740000000003E-05 |
| Follicular-VS-Other |
1.091440E-01 |
| Follicular-VS-Normal |
7.449200E-04 |
| Other-VS-Normal |
2.760200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.81678999999768E-05 |
| Normal-vs-N1 |
1.97000000001779E-06 |
| N0-vs-N1 |
1.050220E-01 |
|
|
